Top

Cardiovascular Intervention and Therapeutics

Published in:

01-01-2022 | Ticagrelor | Expert Consensus Document

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022

Authors: Yukio Ozaki, Hironori Hara, Yoshinobu Onuma, Yuki Katagiri, Tetsuya Amano, Yoshio Kobayashi, Takashi Muramatsu, Hideki Ishii, Ken Kozuma, Nobuhiro Tanaka, Hitoshi Matsuo, Shiro Uemura, Kazushige Kadota, Yutaka Hikichi, Kenichi Tsujita, Junya Ako, Yoshihisa Nakagawa, Yoshihiro Morino, Ichiro Hamanaka, Nobuo Shiode, Junya Shite, Junko Honye, Tetsuo Matsubara, Kazuya Kawai, Yasumi Igarashi, Atsunori Okamura, Takayuki Ogawa, Yoshisato Shibata, Takafumi Tsuji, Junji Yajima, Kaoru Iwabuchi, Nobuo Komatsu, Teruyasu Sugano, Masaru Yamaki, Shinichiro Yamada, Hiroaki Hirase, Yuusuke Miyashita, Fuminobu Yoshimachi, Masakazu Kobayashi, Jiro Aoki, Hirotaka Oda, Yoshiaki Katahira, Kinzo Ueda, Masami Nishino, Koichi Nakao, Ichiro Michishita, Takafumi Ueno, Taku Inohara, Shun Kohsaka, Tevfik F. Ismail, Patrick W. Serruys, Masato Nakamura, Hiroyoshi Yokoi, Yuji Ikari, The Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Cardiovascular Interventional Therapeutics (CVIT)

Published in: Cardiovascular Intervention and Therapeutics | Issue 1/2022

Abstract

Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Interventional and Therapeutics (CVIT) society proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018. Updated guidelines for the management of AMI were published by the European Society of Cardiology (ESC) in 2017 and 2020. Major changes in the guidelines for STEMI patients included: (1) radial access and drug-eluting stents (DES) over bare-metal stents (BMS) were recommended as a Class I indication, (2) complete revascularization before hospital discharge (either immediate or staged) is now considered as Class IIa recommendation. In 2020, updated guidelines for Non-ST-Elevation Myocardial Infarction (NSTEMI) patients, the followings were changed: (1) an early invasive strategy within 24 h is recommended in patients with NSTEMI as a Class I indication, (2) complete revascularization in NSTEMI patients without cardiogenic shock is considered as Class IIa recommendation, and (3) in patients with atrial fibrillation following a short period of triple antithrombotic therapy, dual antithrombotic therapy (e.g., DOAC and single oral antiplatelet agent preferably clopidogrel) is recommended, with discontinuation of the antiplatelet agent after 6 to 12 months. Furthermore, an aspirin-free strategy after PCI has been investigated in several trials those have started to show the safety and efficacy. The Task Force on Primary PCI of the CVIT group has now proposed the updated expert consensus document for the management of AMI focusing on procedural aspects of primary PCI in 2022 version.

Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, Mckinlay SM, Lejemtel TH. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999;341:625–34. https://doi.org/10.1056/nejm199908263410901.CrossRefPubMed

Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, Mcfadden EP, Dubien PY, Cattan S, Boullenger E, Machecourt J, Lacroute JM, Cassagnes J, Dissait F, Touboul P. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet (London, England). 2002;360:825–9. https://doi.org/10.1016/s0140-6736(02)09963-4.CrossRef

Widimsky P, Budesinsky T, Vorac D, Groch L, Zelizko M, Aschermann M, Branny M, St’asek J, Formanek P. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial–PRAGUE-2. Eur Heart J. 2003;24:94–104.CrossRef

Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, Leizorovicz A, Touboul P. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation. 2003;108:2851–6. https://doi.org/10.1161/01.cir.0000103122.10021.f2.CrossRefPubMed

Lincoff AM, Califf RM, Van De Werf F, Willerson JT, White HD, Armstrong PW, Guetta V, Gibler WB, Hochman JS, Bode C, Vahanian A, Steg PG, Ardissino D, Savonitto S, Bar F, Sadowski Z, Betriu A, Booth JE, Wolski K, Waller M, Topol EJ. Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. JAMA. 2002;288:2130–5.CrossRef

Zijlstra F, Beukema WP, Vant Hof AW, Liem A, Reiffers S, Hoorntje JC, Suryapranata H, De Boer MJ. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol. 1997;29:908–12.CrossRef

Zijlstra F, De Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328:680–4. https://doi.org/10.1056/nejm199303113281002.CrossRefPubMed

Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. PRAGUE Study Eur Heart J. 2000;21:823–31. https://doi.org/10.1053/euhj.1999.1993.CrossRefPubMed

De Boer MJ, Ottervanger JP, Van Hof AW, Hoorntje JC, Suryapranata H, Zijlstra F. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol. 2002;39:1723–8.CrossRef

10.

Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, Okeefe J, Overlie P, Donohue B, Chelliah N, Timmis GC, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The primary angioplasty in myocardial infarction study group. N Engl J Med. 1993;328:673–9. https://doi.org/10.1056/nejm199303113281001.CrossRefPubMed

11.

Ribichini F, Steffenino G, Dellavalle A, Ferrero V, Vado A, Feola M, Uslenghi E. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study. J Am Coll Cardiol. 1998;32:1687–94.CrossRef

12.

Garcia E, Elizaga J, Perez-Castellano N, Serrano JA, Soriano J, Abeytua M, Botas J, Rubio R, Lopez De Sa E, Lopez-Sendon JL, Delcan JL. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. J Am Coll Cardiol. 1999;33:605–11.CrossRef

13.

Investigators. GUOSTOOCaIaCSGIaS,. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 1997;336:1621–8. https://doi.org/10.1056/nejm199706053362301.CrossRef

14.

Schomig A, Kastrati A, Dirschinger J, Mehilli J, Schricke U, Pache J, Martinoff S, Neumann FJ, Schwaiger M. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med. 2000;343:385–91. https://doi.org/10.1056/nejm200008103430602.CrossRefPubMed

15.

Vermeer F, Oude Ophuis AJ, Vd Berg EJ, Brunninkhuis LG, Werter CJ, Boehmer AG, Lousberg AH, Dassen WR, Bar FW. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart (Br Card Soc). 1999;82:426–31.

16.

Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J, Martinoff S, Neumann FJ, Nekolla S, Blasini R, Seyfarth M, Schwaiger M, Schomig A. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. Lancet (Lond, Engl). 2002;359:920–5. https://doi.org/10.1016/s0140-6736(02)08022-4.CrossRef

17.

Aversano T, Aversano LT, Passamani E, Knatterud GL, Terrin ML, Williams DO, Forman SA. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA. 2002;287:1943–51.CrossRef

18.

Grines CL, Westerhausen DR Jr, Grines LL, Hanlon JT, Logemann TL, Niemela M, Weaver WD, Graham M, Boura J, Oneill WW, Balestrini C. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. J Am Coll Cardiol. 2002;39:1713–9.CrossRef

19.

Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349:733–42. https://doi.org/10.1056/NEJMoa025142.CrossRefPubMed

20.

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsky P. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2017. https://doi.org/10.1093/eurheartj/ehx393.CrossRefPubMed

21.

Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, Gale CP, Gilard M, Jobs A, Juni P, Lambrinou E, Lewis BS, Mehilli J, Meliga E, Merkely B, Mueller C, Roffi M, Rutten FH, Sibbing D, Siontis GCM, Group ESCSD. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289–367. https://doi.org/10.1093/eurheartj/ehaa575.CrossRef

22.

Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, Vant Hof A, Widimsky P, Zahger D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–619. https://doi.org/10.1093/eurheartj/ehs215.CrossRefPubMed

23.

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsky P, Group ESCSD. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–77. https://doi.org/10.1093/eurheartj/ehx393.CrossRefPubMed

24.

Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, Vant Hof A, Widimsky P, Zahger D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–619. https://doi.org/10.1093/eurheartj/ehs215.CrossRefPubMed

25.

Oikawa J, Fukaya H, Ako J, Nakao K, Ozaki Y, Kimura K, Noguchi T, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Miyamoto Y, Ogawa H, Ishihara M. Risk factors of in-hospital lethal arrhythmia following acute myocardial infarction in patients undergoing primary percutaneous coronary intervention - insight from the J-MINUET study. Circ Rep. 2019;2:17–23. https://doi.org/10.1253/circrep.CR-19-0081.CrossRefPubMedPubMedCentral

26.

Okuno T, Aoki J, Tanabe K, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Ohshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M. Association of onset-season with characteristics and long-term outcomes in acute myocardial infarction patients: results from the Japanese registry of acute myocardial infarction diagnosed by universal definition (J-MINUET) substudy. Heart Vessels. 2019;34:1899–908. https://doi.org/10.1007/s00380-019-01426-w.CrossRefPubMed

27.

Ishihara M, Fujino M, Ogawa H, Yasuda S, Noguchi T, Nakao K, Ozaki Y, Kimura K, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Tsujita K, Nishimura K, Miyamoto Y. Clinical presentation, management and outcome of Japanese patients with acute myocardial infarction in the troponin era - Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET). Circ J. 2015;79:1255–62. https://doi.org/10.1253/circj.CJ-15-0217.CrossRefPubMed

28.

Ishihara M, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Fujino M, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Uematsu M, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Tobaru T, Oshima S, Nakai M, Nishimura K, Miyamoto Y, Ogawa H. Long-term outcomes of non-ST-elevation myocardial infarction without creatine kinase elevation: the J-MINUET study. Circ J. 2017;81:958–65. https://doi.org/10.1253/circj.CJ-17-0033.CrossRefPubMed

29.

Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, Kimura T, Matsubara T, Ikari Y, Kimura K, Tsukahara K, Origasa H, Morino Y, Tsutsui H, Kobayashi M, Isshiki T. Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry. Circ J. 2013;77:934–43.CrossRef

30.

Miyachi H, Takagi A, Miyauchi K, Yamasaki M, Tanaka H, Yoshikawa M, Saji M, Suzuki M, Yamamoto T, Shimizu W, Nagao K, Takayama M. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort. Heart Vessels. 2016;31:1740–51. https://doi.org/10.1007/s00380-015-0791-9.CrossRefPubMed

31.

Kojima S, Nishihira K, Takegami M, Nakao YM, Honda S, Takahashi J, Takayama M, Shimokawa H, Sumiyoshi T, Ogawa H, Kimura K, Yasuda S. Nationwide real-world database of 20,462 patients enrolled in the Japanese Acute Myocardial Infarction Registry (JAMIR): impact of emergency coronary intervention in a super-aging population. Int J Cardiol Heart Vasc. 2018;20:1–6. https://doi.org/10.1016/j.ijcha.2018.06.003.CrossRefPubMedPubMedCentral

32.

Honda S, Nishihira K, Kojima S, Takegami M, Asaumi Y, Suzuki M, Kosuge M, Takahashi J, Sakata Y, Takayama M, Sumiyoshi T, Ogawa H, Kimura K, Yasuda S. Rationale, design, and baseline characteristics of the prospective japan acute myocardial infarction registry (JAMIR). Cardiovasc Drugs Ther. 2019;33:97–103. https://doi.org/10.1007/s10557-018-6839-1.CrossRefPubMed

33.

Yasuda S, Honda S, Takegami M, Nishihira K, Kojima S, Asaumi Y, Suzuki M, Kosuge M, Takahashi J, Sakata Y, Takayama M, Sumiyoshi T, Ogawa H, Kimura K. Contemporary antiplatelet therapy and clinical outcomes of japanese patients with acute myocardial infarction: results from the prospective Japan Acute Myocardial Infarction Registry (JAMIR). Circ J. 2019;83:1633–43. https://doi.org/10.1253/circj.CJ-19-0145.CrossRefPubMed

34.

Suzuki M, Nishihira K, Takegami M, Honda S, Kojima S, Takayama M, Sumiyoshi T, Ogawa H, Kimura K, Yasuda S. Clinical profiles and outcomes in the treatment of acute myocardial infarction in Japan of aging society. Heart Vessels. 2020;35:1681–8. https://doi.org/10.1007/s00380-020-01654-5.CrossRefPubMed

35.

Mori H, Suzuki H, Nishihira K, Honda S, Kojima S, Takegami M, Takahashi J, Itoh T, Watanabe T, Takenaka T, Ito M, Takayama M, Kario K, Sumiyoshi T, Kimura K, Yasuda S. In-hospital morality associated with acute myocardial infarction was inversely related with the number of coronary risk factors in patients from a Japanese nation-wide real-world database. Int J Cardiol Hypertens. 2020;6: 100039. https://doi.org/10.1016/j.ijchy.2020.100039.CrossRefPubMedPubMedCentral

36.

Kanaoka K, Okayama S, Yoneyama K, Nakai M, Nishimura K, Kawata H, Horii M, Kawakami R, Okura H, Miyamoto Y, Akashi Y, Saito Y. Number of board-certified cardiologists and acute myocardial infarction-related mortality in Japan - JROAD and JROAD-DPC registry analysis. Circ J. 2018;82:2845–51. https://doi.org/10.1253/circj.CJ-18-0487.CrossRefPubMed

37.

Uemura S, Okamoto H, Nakai M, Nishimura K, Miyamoto Y, Yasuda S, Tanaka N, Kohsaka S, Kadota K, Saito Y, Tsutsui H, Komuro I, Ikari Y, Ogawa H, Nakamura M. Primary percutaneous coronary intervention in elderly patients with acute myocardial infarction - an analysis from a japanese nationwide claim-based database. Circ J. 2019;83:1229–38. https://doi.org/10.1253/circj.CJ-19-0004.CrossRef

38.

Matoba T, Sakamoto K, Nakai M, Ichimura K, Mohri M, Tsujita Y, Yamasaki M, Ueki Y, Tanaka N, Hokama Y, Fukutomi M, Hashiba K, Fukuhara R, Suwa S, Matsuura H, Hosoda H, Nakashima T, Tahara Y, Sumita Y, Nishimura K, Miyamoto Y, Yonemoto N, Yagi T, Tachibana E, Nagao K, Ikeda T, Sato N, Tsutsui H. Institutional characteristics and prognosis of acute myocardial infarction with cardiogenic shock in Japan: analysis from the JROAD/JROAD-DPC database. Circ J. 2021. https://doi.org/10.1253/circj.CJ-20-0655.CrossRefPubMed

39.

Sakakura K, Inohara T, Kohsaka S, Amano T, Uemura S, Ishii H, Kadota K, Nakamura M, Funayama H, Fujita H, Momomura SI. Incidence and determinants of complications in rotational atherectomy: insights from the national clinical data (J-PCI Registry). Circulation. 2016. https://doi.org/10.1161/circinterventions.116.004278.CrossRefPubMed

40.

Numasawa Y, Inohara T, Ishii H, Kuno T, Kodaira M, Kohsaka S, Fujii K, Uemura S, Amano T, Kadota K, Nakamura M. Comparison of outcomes of women versus men with non-st-elevation acute coronary syndromes undergoing percutaneous coronary intervention (from the Japanese Nationwide Registry). Am J Cardiol. 2017;119:826–31. https://doi.org/10.1016/j.amjcard.2016.11.034.CrossRefPubMed

41.

Yamaji K, Kohsaka S, Morimoto T, Fujii K, Amano T, Uemura S, Akasaka T, Kadota K, Nakamura M, Kimura T. Relation of ST-segment elevation myocardial infarction to daily ambient temperature and air pollutant levels in a Japanese nationwide percutaneous coronary intervention registry. Am J Cardiol. 2017;119:872–80. https://doi.org/10.1016/j.amjcard.2016.11.041.CrossRefPubMed

42.

Inohara T, Kohsaka S, Yamaji K, Amano T, Fujii K, Oda H, Uemura S, Kadota K, Miyata H, Nakamura M. Impact of institutional and operator volume on short-term outcomes of percutaneous coronary intervention: a report from the japanese nationwide registry. JACC Cardiovasc Interv. 2017;10:918–27. https://doi.org/10.1016/j.jcin.2017.02.015.CrossRefPubMed

43.

Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Ting HH, Ogara PT, Kushner FG, Ascheim DD, Brindis RG, Casey DE, Chung MK, De Lemos JA, Diercks DB, Fang JC, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. J Am Coll Cardiol. 2016;67:1235–50. https://doi.org/10.1016/j.jacc.2015.10.005.CrossRefPubMed

44.

Fox KA, Clayton TC, Damman P, Pocock SJ, De Winter RJ, Tijssen JG, Lagerqvist B, Wallentin L. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol. 2010;55:2435–45. https://doi.org/10.1016/j.jacc.2010.03.007.CrossRefPubMed

45.

Wallentin L, Lindhagen L, Arnstrom E, Husted S, Janzon M, Johnsen SP, Kontny F, Kempf T, Levin LA, Lindahl B, Stridsberg M, Stahle E, Venge P, Wollert KC, Swahn E, Lagerqvist B. Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study. Lancet (Lond, Engl). 2016;388:1903–11. https://doi.org/10.1016/s0140-6736(16)31276-4.CrossRef

46.

Kofoed KF, Kelbæk H, Hansen PR, Torp-Pedersen C, Høfsten D, Kløvgaard L, Holmvang L, Helqvist S, Jørgensen E, Galatius S, Pedersen F, Bang L, Saunamaki K, Clemmensen P, Linde JJ, Heitmann M, Wendelboe Nielsen O, Raymond IE, Kristiansen OP, Svendsen IH, Bech J, Dominguez Vall-Lamora MH, Kragelund C, Hansen TF, Dahlgaard Hove J, Jørgensen T, Fornitz GG, Steffensen R, Jurlander B, Abdulla J, Lyngbæk S, Elming H, Therkelsen SK, Abildgaard U, Jensen JS, Gislason G, Køber LV, Engstrøm T. Early versus standard care invasive examination and treatment of patients with non-st-segment elevation acute coronary syndrome. Circulation. 2018;138:2741–50. https://doi.org/10.1161/circulationaha.118.037152.CrossRefPubMed

47.

Komiyama K, Nakamura M, Tanabe K, Niikura H, Fujimoto H, Oikawa K, Daida H, Yamamoto T, Nagao K, Takayama M. In-hospital mortality analysis of Japanese patients with acute coronary syndrome using the Tokyo CCU Network database: applicability of the GRACE risk score. J Cardiol. 2017. https://doi.org/10.1016/j.jjcc.2017.09.006.CrossRefPubMed

48.

Ozaki Y, Nakao K, Kimura K, Jynya A, Noguchi T, Yasuda S, Takahashi H, Nishimura K, Miyamoto Y, Ishihara M. Impact of chronic kidney disease (Ckd) on in-hospital and 3-year clinical outcomes in patients with acute myocardial infarction (Ami) treated by contemporary pci and optimal medical therapy (Omt): insights from the J-Minuet study. J Am Coll Cardiol. 2018;71:1391–1391. https://doi.org/10.1016/S0735-1097(18)31932-6.CrossRef

49.

Lemkes JS, Janssens GN, Van Der Hoeven NW, Jewbali LSD, Dubois EA, Meuwissen M, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, Baak R, Vlachojannis GJ, Eikemans BJW, Van Der Harst P, Van Der Horst ICC, Voskuil M, Van Der Heijden JJ, Beishuizen A, Stoel M, Camaro C, Van Der Hoeven H, Henriques JP, Vlaar APJ, Vink MA, Van Den Bogaard B, Heestermans T, De Ruijter W, Delnoij TSR, Crijns H, GaJ J, Oemrawsingh PV, Gosselink MTM, Plomp K, Magro M, Elbers PWG, Van De Ven PM, Oudemans-Van Straaten HM, Van Royen N. Coronary angiography after cardiac arrest without ST-segment elevation. N Engl J Med. 2019;380:1397–407. https://doi.org/10.1056/NEJMoa1816897.CrossRefPubMed

50.

Lemkes JS, Janssens GN, Van Der Hoeven NW, Jewbali LSD, Dubois EA, Meuwissen MM, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, Baak RR, Vlachojannis GJ, Eikemans BJW, Van Der Harst P, Van Der Horst ICC, Voskuil M, Van Der Heijden JJ, Beishuizen A, Stoel M, Camaro C, Van Der Hoeven H, Henriques JP, Vlaar APJ, Vink MA, Van Den Bogaard B, Heestermans T, De Ruijter W, Delnoij TSR, Crijns H, GaJ J, Oemrawsingh PV, Gosselink MTM, Plomp K, Magro M, Elbers PWG, Spoormans EM, Van De Ven PM, Oudemans-Van Straaten HM, Van Royen N. Coronary angiography after cardiac arrest without ST segment elevation: one-year outcomes of the COACT randomized clinical trial. JAMA Cardiol. 2020;5:1–8. https://doi.org/10.1001/jamacardio.2020.3670.CrossRefPubMedCentral

51.

Wiviott SD, Braunwald E, Mccabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001–15. https://doi.org/10.1056/NEJMoa0706482.CrossRefPubMed

52.

Saito S, Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, Takayama M, Kitagawa K, Nishikawa M, Miyazaki S, Nakamura M. Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study. Circ J. 2014;78:1684–92.CrossRef

53.

Sahlen A, Varenhorst C, Lagerqvist B, Renlund H, Omerovic E, Erlinge D, Wallentin L, James SK, Jernberg T. Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry. Eur Heart J. 2016;37:3335–42. https://doi.org/10.1093/eurheartj/ehw284.CrossRefPubMed

54.

Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Freij A, Thorsen M. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045–57. https://doi.org/10.1056/NEJMoa0904327.CrossRefPubMed

55.

Schupke S, Neumann FJ, Menichelli M, Mayer K, Bernlochner I, Wohrle J, Richardt G, Liebetrau C, Witzenbichler B, Antoniucci D, Akin I, Bott-Flugel L, Fischer M, Landmesser U, Katus HA, Sibbing D, Seyfarth M, Janisch M, Boncompagni D, Hilz R, Rottbauer W, Okrojek R, Mollmann H, Hochholzer W, Migliorini A, Cassese S, Mollo P, Xhepa E, Kufner S, Strehle A, Leggewie S, Allali A, Ndrepepa G, Schuhlen H, Angiolillo DJ, Hamm CW, Hapfelmeier A, Tolg R, Trenk D, Schunkert H, Laugwitz KL, Kastrati A. Ticagrelor or prasugrel in patients with acute coronary syndromes. N Engl J Med. 2019;381:1524–34. https://doi.org/10.1056/NEJMoa1908973.CrossRefPubMed

56.

Montalescot G, Zeymer U, Silvain J, Boulanger B, Cohen M, Goldstein P, Ecollan P, Combes X, Huber K, Pollack C Jr, Benezet JF, Stibbe O, Filippi E, Teiger E, Cayla G, Elhadad S, Adnet F, Chouihed T, Gallula S, Greffet A, Aout M, Collet JP, Vicaut E. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. Lancet (Lond, Engl). 2011;378:693–703. https://doi.org/10.1016/s0140-6736(11)60876-3.CrossRef

57.

Silvain J, Beygui F, Barthelemy O, Pollack C Jr, Cohen M, Zeymer U, Huber K, Goldstein P, Cayla G, Collet JP, Vicaut E, Montalescot G. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. BMJ (Clin Res ed). 2012;344: e553. https://doi.org/10.1136/bmj.e553.CrossRef

58.

Capodanno D, Gargiulo G, Capranzano P, Mehran R, Tamburino C, Stone GW. Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10,350 patients from five randomized clinical trials. Eur Heart J Acute Cardiovasc Care. 2016;5:253–62. https://doi.org/10.1177/2048872615572599.CrossRefPubMed

59.

Valgimigli M, Frigoli E, Leonardi S, Rothenbuhler M, Gagnor A, Calabro P, Garducci S, Rubartelli P, Briguori C, Ando G, Repetto A, Limbruno U, Garbo R, Sganzerla P, Russo F, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Presbitero P, Santarelli A, Sardella G, Varbella F, Tresoldi S, De Cesare N, Rigattieri S, Zingarelli A, Tosi P, Vant Hof A, Boccuzzi G, Omerovic E, Sabate M, Heg D, Juni P, Vranckx P. Bivalirudin or unfractionated heparin in acute coronary syndromes. N Engl J Med. 2015;373:997–1009. https://doi.org/10.1056/NEJMoa1507854.CrossRefPubMed

60.

Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358:2218–30. https://doi.org/10.1056/NEJMoa0708191.CrossRefPubMed

61.

Kastrati A, Neumann FJ, Mehilli J, Byrne RA, Iijima R, Buttner HJ, Khattab AA, Schulz S, Blankenship JC, Pache J, Minners J, Seyfarth M, Graf I, Skelding KA, Dirschinger J, Richardt G, Berger PB, Schomig A. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. N Engl J Med. 2008;359:688–96. https://doi.org/10.1056/NEJMoa0802944.CrossRefPubMed

62.

Ndrepepa G, Schulz S, Keta D, Mehilli J, Birkmeier A, Massberg S, Laugwitz KL, Neumann FJ, Seyfarth M, Berger PB, Schomig A, Kastrati A. Bleeding after percutaneous coronary intervention with Bivalirudin or unfractionated Heparin and one-year mortality. Am J Cardiol. 2010;105:163–7. https://doi.org/10.1016/j.amjcard.2009.08.668.CrossRefPubMed

63.

Erlinge D, Omerovic E, Frobert O, Linder R, Danielewicz M, Hamid M, Swahn E, Henareh L, Wagner H, Hardhammar P, Sjogren I, Stewart J, Grimfjard P, Jensen J, Aasa M, Robertsson L, Lindroos P, Haupt J, Wikstrom H, Ulvenstam A, Bhiladvala P, Lindvall B, Lundin A, Todt T, Ioanes D, Ramunddal T, Kellerth T, Zagozdzon L, Gotberg M, Andersson J, Angeras O, Ostlund O, Lagerqvist B, Held C, Wallentin L, Schersten F, Eriksson P, Koul S, James S. Bivalirudin versus heparin monotherapy in myocardial infarction. N Engl J Med. 2017;377:1132–42. https://doi.org/10.1056/NEJMoa1706443.CrossRefPubMed

64.

Nakagawa Y, Nobuyoshi M, Yamaguchi T, Meguro T, Yokoi H, Kimura T, Hosoda S, Kanmatsuse K, Matsumori A, Sasayama S. Efficacy of abciximab for patients undergoing balloon angioplasty: data from Japanese evaluation of c7E3 Fab for elective and primary PCI organization in randomized trial (JEPPORT). Circ J. 2009;73:145–51.CrossRef

65.

Romagnoli E, Biondi-Zoccai G, Sciahbasi A, Politi L, Rigattieri S, Pendenza G, Summaria F, Patrizi R, Borghi A, Di Russo C, Moretti C, Agostoni P, Loschiavo P, Lioy E, Sheiban I, Sangiorgi G. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol. 2012;60:2481–9. https://doi.org/10.1016/j.jacc.2012.06.017.CrossRefPubMed

66.

Jolly SS, Yusuf S, Cairns J, Niemela K, Xavier D, Widimsky P, Budaj A, Niemela M, Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Gao P, Afzal R, Joyner CD, Chrolavicius S, Mehta SR. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet (Lond, Engl). 2011;377:1409–20. https://doi.org/10.1016/s0140-6736(11)60404-2.CrossRef

67.

Vranckx P, Frigoli E, Rothenbuhler M, Tomassini F, Garducci S, Ando G, Picchi A, Sganzerla P, Paggi A, Ugo F, Ausiello A, Sardella G, Franco N, Nazzaro M, De Cesare N, Tosi P, Falcone C, Vigna C, Mazzarotto P, Di Lorenzo E, Moretti C, Campo G, Penzo C, Pasquetto G, Heg D, Juni P, Windecker S, Valgimigli M. Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation. Eur Heart J. 2017;38:1069–80. https://doi.org/10.1093/eurheartj/ehx048.CrossRefPubMed

68.

Saito S, Tanaka S, Hiroe Y, Miyashita Y, Takahashi S, Tanaka K, Satake S. Comparative study on transradial approach vs. transfemoral approach in primary stent implantation for patients with acute myocardial infarction: results of the test for myocardial infarction by prospective unicenter randomization for access sites (TEMPURA) trial. Catheter Cardiovasc Interv. 2003;59:26–33. https://doi.org/10.1002/ccd.10493.CrossRefPubMed

69.

Saito S, Isshiki T, Kimura T, Ogawa H, Yokoi H, Nishikawa M, Miyazaki S, Tanaka Y, Nakamura M. Impact of arterial access route on bleeding complications in japanese patients undergoing percutaneous coronary intervention- insight from the PRASFIT trial. Circ J. 2015;79:1928–37. https://doi.org/10.1253/circj.CJ-15-0276.CrossRefPubMed

70.

Yamashita Y, Shiomi H, Morimoto T, Yaku H, Kaji S, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Abe M, Akao M, Nagao K, Shizuta S, Ono K, Kimura T. Transradial versus transfemoral approach in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction: insight from the CREDO-Kyoto AMI registry. Heart Vessels. 2017;32:1448–57. https://doi.org/10.1007/s00380-017-1021-4.CrossRefPubMed

71.

Schaar JA, Muller JE, Falk E, Virmani R, Fuster V, Serruys PW, Colombo A, Stefanadis C, Ward Casscells S, Moreno PR, Maseri A, Van Der Steen AF. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini. Greece Eur Heart J. 2004;25:1077–82. https://doi.org/10.1016/j.ehj.2004.01.002.CrossRefPubMed

72.

Arbustini E, Dal Bello B, Morbini P, Burke AP, Bocciarelli M, Specchia G, Virmani R. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart. 1999;82:269–72. https://doi.org/10.1136/hrt.82.3.269.CrossRefPubMedPubMedCentral

73.

Jia H, Abtahian F, Aguirre AD, Lee S, Chia S, Lowe H, Kato K, Yonetsu T, Vergallo R, Hu S, Tian J, Lee H, Park SJ, Jang YS, Raffel OC, Mizuno K, Uemura S, Itoh T, Kakuta T, Choi SY, Dauerman HL, Prasad A, Toma C, Mcnulty I, Zhang S, Yu B, Fuster V, Narula J, Virmani R, Jang IK. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol. 2013;62:1748–58. https://doi.org/10.1016/j.jacc.2013.05.071.CrossRefPubMed

74.

Ozaki Y, Okumura M, Ismail TF, Motoyama S, Naruse H, Hattori K, Kawai H, Sarai M, Takagi Y, Ishii J, Anno H, Virmani R, Serruys PW, Narula J. Coronary CT angiographic characteristics of culprit lesions in acute coronary syndromes not related to plaque rupture as defined by optical coherence tomography and angioscopy. Eur Heart J. 2011;32:2814–23. https://doi.org/10.1093/eurheartj/ehr189.CrossRefPubMed

75.

Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, Tanimoto T, Matsuo Y, Masho T, Kitabata H, Tsuda K, Tomobuchi Y, Akasaka T. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007;50:933–9. https://doi.org/10.1016/j.jacc.2007.04.082.CrossRefPubMed

76.

Nijssen EC, Rennenberg RJ, Nelemans PJ, Essers BA, Janssen MM, Vermeeren MA, Ommen VV, Wildberger JE. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet (Lond, Engl). 2017;389:1312–22. https://doi.org/10.1016/s0140-6736(17)30057-0.CrossRef

77.

Jolly SS, James S, Dzavik V, Cairns JA, Mahmoud KD, Zijlstra F, Yusuf S, Olivecrona GK, Renlund H, Gao P, Lagerqvist B, Alazzoni A, Kedev S, Stankovic G, Meeks B, Frobert O. Thrombus aspiration in ST-segment-elevation myocardial infarction: an individual patient meta-analysis: thrombectomy trialists collaboration. Circulation. 2017;135:143–52. https://doi.org/10.1161/circulationaha.116.025371.CrossRefPubMed

78.

Svilaas T, Vlaar PJ, Van Der Horst IC, Diercks GF, De Smet BJ, Van Den Heuvel AF, Anthonio RL, Jessurun GA, Tan ES, Suurmeijer AJ, Zijlstra F. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008;358:557–67. https://doi.org/10.1056/NEJMoa0706416.CrossRefPubMed

79.

Burzotta F, De Vita M, Gu YL, Isshiki T, Lefevre T, Kaltoft A, Dudek D, Sardella G, Orrego PS, Antoniucci D, De Luca L, Biondi-Zoccai GG, Crea F, Zijlstra F. Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. Eur Heart J. 2009;30:2193–203. https://doi.org/10.1093/eurheartj/ehp348.CrossRefPubMed

80.

Ikari Y, Sakurada M, Kozuma K, Kawano S, Katsuki T, Kimura K, Suzuki T, Yamashita T, Takizawa A, Misumi K, Hashimoto H, Isshiki T. Upfront thrombus aspiration in primary coronary intervention for patients with ST-segment elevation acute myocardial infarction: report of the VAMPIRE (VAcuuM asPIration thrombus REmoval) trial. JACC Cardiovasc Interv. 2008;1:424–31. https://doi.org/10.1016/j.jcin.2008.06.004.CrossRefPubMed

81.

Nakatani D, Sato H, Sakata Y, Mizuno H, Shimizu M, Suna S, Nanto S, Hirayama A, Ito H, Fujii K, Hori M. Effect of intracoronary thrombectomy on 30-day mortality in patients with acute myocardial infarction. Am J Cardiol. 2007;100:1212–7. https://doi.org/10.1016/j.amjcard.2007.05.040.CrossRefPubMed

82.

Hara H, Nakamura M, Komatsu H, Ikeda N, Shinji H, Makino K, Itaya H, Yamamoto M, Itou N, Tsunoda T, Sugi K. Comparison of the in vitro performance of 6 and 7 French aspiration catheters. EuroIntervention. 2007;2:487–92.PubMed

83.

Anzai H, Yoneyama S, Tsukagoshi M, Miyake T, Kikuchi T, Sakurada M. Rescue percutaneous thrombectomy system provides better angiographic coronary flow and does not increase the in-hospital cost in patients with acute myocardial infarction. Circ J. 2003;67:768–74.CrossRef

84.

Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Dulas D, Rutherford BD, Antoniucci D, Krucoff MW, Gibbons RJ, Jones D, Lansky AJ, Mehran R. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA. 2005;293:1063–72. https://doi.org/10.1001/jama.293.9.1063.CrossRefPubMed

85.

Bavry AA, Kumbhani DJ, Bhatt DL. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. Eur Heart J. 2008;29:2989–3001. https://doi.org/10.1093/eurheartj/ehn421.CrossRefPubMed

86.

Isshiki T, Kozuma K, Kyono H, Suzuki N, Yokoyama N, Yamamoto Y. Initial clinical experience with distal embolic protection using “Filtrap”, a novel filter device with a self-expandable spiral basket in patients undergoing percutaneous coronary intervention. Cardiovasc Interv Ther. 2011;26:12–7. https://doi.org/10.1007/s12928-010-0027-y.CrossRefPubMed

87.

Muramatsu T, Kozuma K, Tsukahara R, Ito Y, Fujita N, Suwa S, Koyama S, Saitoh M, Kamiya H, Nakamura M. Comparison of myocardial perfusion by distal protection before and after primary stenting for acute myocardial infarction: angiographic and clinical results of a randomized controlled trial. Catheter Cardiovasc Interv. 2007;70:677–82. https://doi.org/10.1002/ccd.21190.CrossRefPubMed

88.

Stone GW, Maehara A, Muller JE, Rizik DG, Shunk KA, Ben-Yehuda O, Genereux P, Dressler O, Parvataneni R, Madden S, Shah P, Brilakis ES, Kini AS. Plaque characterization to inform the prediction and prevention of periprocedural myocardial infarction during percutaneous coronary intervention: the CANARY trial (coronary assessment by near-infrared of atherosclerotic rupture-prone yellow). JACC Cardiovasc Interv. 2015;8:927–36. https://doi.org/10.1016/j.jcin.2015.01.032.CrossRefPubMed

89.

Hibi K, Kozuma K, Maejima N, Sonoda S, Endo T, Tanaka H, Kyono H, Koshida R, Ishihara T, Awata M, Kume T, Tanabe K, Morino Y, Tsukahara K, Ikari Y, Fujii K, Yamasaki M, Yamanaka T, Sumiyoshi T, Yoshino H, Kimura K, Isshiki T; VAMPIRE 3 Investigators. Long-term clinical outcomes after filter protection during percutaneous coronary intervention in patients with attenuated plaque - 1-year follow up of the VAMPIRE 3 (Vacuum Aspiration Thrombus Reemoval 3) Trial. Circ J. 2020;85(1):44–49. https://doi.org/10.1253/circj.CJ-20-0449.

90.

Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KK, Kuntz RE. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105:1285–90.CrossRef

91.

Ishii H, Ichimiya S, Kanashiro M, Amano T, Imai K, Murohara T, Matsubara T. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation. 2005;112:1284–8. https://doi.org/10.1161/circulationaha.104.530329.CrossRefPubMed

92.

Miyazawa A, Ikari Y, Tanabe K, Nakajima H, Aoki J, Iijima R, Nakayama T, Hatori M, Nakazawa G, Tanimoto S, Onuma Y, Hara K. Intracoronary nicorandil prior to reperfusion in acute myocardial infarction. EuroIntervention. 2006;2:211–7.PubMed

93.

Kobatake R, Sato T, Fujiwara Y, Sunami H, Yoshioka R, Ikeda T, Saito H, Ujihira T. Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction. Heart Vessels. 2011;26:379–84. https://doi.org/10.1007/s00380-010-0065-5.CrossRefPubMed

94.

Niu X, Zhang J, Bai M, Peng Y, Sun S, Zhang Z. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis. BMC Cardiovasc Disord. 2018;18:3. https://doi.org/10.1186/s12872-017-0722-z.CrossRefPubMedPubMedCentral

95.

Ndrepepa G, Kastrati A. Mechanical strategies to enhance myocardial salvage during primary percutaneous coronary intervention in patients with STEMI. EuroIntervention. 2016;12:319–28. https://doi.org/10.4244/eijv12i3a52.CrossRefPubMed

96.

Loubeyre C, Morice MC, Lefevre T, Piechaud JF, Louvard Y, Dumas P. A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. J Am Coll Cardiol. 2002;39:15–21.CrossRef

97.

Mockel M, Vollert J, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Kornowski R, Dudek D, Farkouh ME, Parise H, Mehran R, Stone GW. Comparison of direct stenting with conventional stent implantation in acute myocardial infarction. Am J Cardiol. 2011;108:1697–703. https://doi.org/10.1016/j.amjcard.2011.07.040.CrossRefPubMed

98.

Dziewierz A, Siudak Z, Rakowski T, Kleczynski P, Zasada W, Dubiel JS, Dudek D. Impact of direct stenting on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER registry). Catheter Cardiovasc Interv. 2014;84:925–31. https://doi.org/10.1002/ccd.25266.CrossRefPubMed

99.

Barbato E, Marco J, Wijns W. Direct stenting. Eur Heart J. 2003;24:394–403.CrossRef

100.

Mintz GS. Remodeling and restenosis: observations from serial intravascular ultrasound studies. Curr Interv Cardiol Rep. 2000;2:316–25.PubMed

101.

Ozaki Y, Violaris AG, Hamburger JN, Melkert R, Foley D, Keane D, de Feyter PJ, Serruys PW. Short- and long-term clinical and quantitative angiographic results with the new less shortening Wallstent for vessel reconstruction in chronic total occlusion. J Am Coll Cardiol 1996;28:354–360.

102.

De Luca G, Suryapranata H, Stone GW, Antoniucci D, Biondi-Zoccai G, Kastrati A, Chiariello M, Marino P. Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials. Int J Cardiol. 2008;126:37–44. https://doi.org/10.1016/j.ijcard.2007.03.112.CrossRefPubMed

103.

Suryapranata H, De Luca G, Vant Hof AW, Ottervanger JP, Hoorntje JC, Dambrink JH, Gosselink AT, Zijlstra F, De Boer MJ. Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomised comparison in a large cohort of unselected patients. Heart (Br Card Soc). 2005;91:641–5. https://doi.org/10.1136/hrt.2004.056705.CrossRef

104.

Saito S, Hosokawa G, Tanaka S, Nakamura S. Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction: final results of the primary angioplasty versus stent implantation in acute myocardial infarction (PASTA) trial. PASTA Trial Investigators. Catheter Cardiovasc Interv. 1999;48:262–8.CrossRef

105.

Tsuchihashi M, Tsutsui H, Shihara M, Tada H, Kono S, Takeshita A. Comparison of outcomes for patients undergoing balloon angioplasty vs coronary stenting for acute myocardial infarction. Circ J. 2003;67:369–74.CrossRef

106.

Laarman GJ, Suttorp MJ, Dirksen MT, Van Heerebeek L, Kiemeneij F, Slagboom T, Van Der Wieken LR, Tijssen JG, Rensing BJ, Patterson M. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med. 2006;355:1105–13. https://doi.org/10.1056/NEJMoa062598.CrossRefPubMed

107.

Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Seyfarth M, Varenne O, Dirksen MT, Percoco G, Varricchio A, Pittl U, Syvanne M, Suttorp MJ, Violini R, Schomig A. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J. 2007;28:2706–13. https://doi.org/10.1093/eurheartj/ehm402.CrossRefPubMed

108.

De Luca G, Stone GW, Suryapranata H, Laarman GJ, Menichelli M, Kaiser C, Valgimigli M, Di Lorenzo E, Dirksen MT, Spaulding C, Pittl U, Violini R, Percoco G, Marino P. Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. Int J Cardiol. 2009;133:213–22. https://doi.org/10.1016/j.ijcard.2007.12.040.CrossRefPubMed

109.

Degertekin M, Serruys PW, Tanabe K, Lee CH, Sousa JE, Colombo A, Morice MC, Ligthart JM, De Feyter PJ. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis. Circulation. 2003;108:2747–50. https://doi.org/10.1161/01.cir.0000103666.25660.77.CrossRefPubMed

110.

Mcfadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet (Lond, Engl). 2004;364:1519–21. https://doi.org/10.1016/s0140-6736(04)17275-9.CrossRef

111.

Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, Gold HK, Burke AP, Kolodgie FD, Virmani R. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation. 2008;118:1138–45. https://doi.org/10.1161/circulationaha.107.762047.CrossRefPubMed

112.

Vink MA, Dirksen MT, Suttorp MJ, Tijssen JG, Van Etten J, Patterson MS, Slagboom T, Kiemeneij F, Laarman GJ. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial. JACC Cardiovasc Interv. 2011;4:24–9. https://doi.org/10.1016/j.jcin.2010.11.003.CrossRefPubMed

113.

Stone SG, Serrao GW, Mehran R, Tomey MI, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Mockel M, Brener SJ, Dangas G, Stone GW. Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial. Circ Cardiovasc Interv. 2014;7:543–51. https://doi.org/10.1161/circinterventions.114.001360.CrossRefPubMed

114.

Gonzalo N, Barlis P, Serruys PW, Garcia-Garcia HM, Onuma Y, Ligthart J, Regar E. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography. JACC Cardiovasc Interv. 2009;2:445–52. https://doi.org/10.1016/j.jcin.2009.01.012.CrossRefPubMed

115.

Jaffe R, Charron T, Puley G, Dick A, Strauss BH. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation. 2008;117:3152–6. https://doi.org/10.1161/circulationaha.107.742312.CrossRefPubMed

116.

Ndrepepa G, Tiroch K, Keta D, Fusaro M, Seyfarth M, Pache J, Mehilli J, Schomig A, Kastrati A. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction. Circ Cardiovasc Interv. 2010;3:27–33. https://doi.org/10.1161/circinterventions.109.896225.CrossRefPubMed

117.

Harrison RW, Aggarwal A, Ou FS, Klein LW, Rumsfeld JS, Roe MT, Wang TY. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol. 2013;111:178–84. https://doi.org/10.1016/j.amjcard.2012.09.015.CrossRefPubMed

118.

Kelbaek H, Engstrom T, Ahtarovski KA, Lonborg J, Vejlstrup N, Pedersen F, Holmvang L, Helqvist S, Saunamaki K, Jorgensen E, Clemmensen P, Klovgaard L, Tilsted HH, Raungaard B, Ravkilde J, Aaroe J, Eggert S, Kober L. Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study. EuroIntervention. 2013;8:1126–33. https://doi.org/10.4244/eijv8i10a175.CrossRefPubMed

119.

Carrick D, Oldroyd KG, Mcentegart M, Haig C, Petrie MC, Eteiba H, Hood S, Owens C, Watkins S, Layland J, Lindsay M, Peat E, Rae A, Behan M, Sood A, Hillis WS, Mordi I, Mahrous A, Ahmed N, Wilson R, Lasalle L, Genereux P, Ford I, Berry C. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI). J Am Coll Cardiol. 2014;63:2088–98. https://doi.org/10.1016/j.jacc.2014.02.530.CrossRefPubMedPubMedCentral

120.

Vos NS, Dirksen MT, Vink MA, Van Nooijen FC, Amoroso G, Herrman JP, Kiemeneij F, Patterson MS, Slagboom T, Van Der Schaaf RJ. Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in Primary Percutaneous coronary intervention in Amsterdam (PAPPA): one-year clinical outcome of a pilot study. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2014;10:584–90. https://doi.org/10.4244/eijv10i5a101.CrossRef

121.

Vos NS, Fagel ND, Amoroso G, Herrman JR, Patterson MS, Piers LH, Van Der Schaaf RJ, Slagboom T, Vink MA. Paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial infarction: the REVELATION randomized trial. JACC Cardiovasc Interv. 2019;12:1691–9. https://doi.org/10.1016/j.jcin.2019.04.016.CrossRefPubMed

122.

Kim JS, Lee HJ, Woong YuC, Kim YM, Hong SJ, Park JH, Choi RK, Choi YJ, Park JS, Kim TH, Jang HJ, Joo HJ, Cho SA, Ro YM, Lim DS. INNOVATION study (impact of immediate stent implantation versus deferred stent implantation on infarct size and microvascular perfusion in patients with st-segment-elevation myocardial infarction). Circulation. 2016. https://doi.org/10.1161/circinterventions.116.004101.CrossRefPubMedPubMedCentral

123.

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Juni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO, Group ESCSD. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40:87–165. https://doi.org/10.1093/eurheartj/ehy394.CrossRefPubMed

124.

Johnson TW, Räber L, Di Mario C, Bourantas C, Jia H, Mattesini A, Gonzalo N, De La Torre Hernandez JM, Prati F, Koskinas K, Joner M, Radu MD, Erlinge D, Regar E, Kunadian V, Maehara A, Byrne RA, Capodanno D, Akasaka T, Wijns W, Mintz GS, Guagliumi G. Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2019;40:2566–84. https://doi.org/10.1093/eurheartj/ehz332.CrossRefPubMed

125.

De Feyter PJ, Ozaki Y, Baptista J, Escaned J, Di Mario C, De Jaegere PP, Serruys PW, Roelandt JR. Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. Circulation. 1995;92:1408–13.CrossRef

126.

Prati F, Uemura S, Souteyrand G, Virmani R, Motreff P, Di Vito L, Biondi-Zoccai G, Halperin J, Fuster V, Ozaki Y, Narula J. OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging. 2013;6:283–7. https://doi.org/10.1016/j.jcmg.2012.12.007.CrossRefPubMed

127.

Jia H, Dai J, Hou J, Xing L, Ma L, Liu H, Xu M, Yao Y, Hu S, Yamamoto E, Lee H, Zhang S, Yu B, Jang IK. Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study). Eur Heart J. 2017;38:792–800. https://doi.org/10.1093/eurheartj/ehw381.CrossRefPubMed

128.

Prati F, Romagnoli E, Gatto L, La Manna A, Burzotta F, Ozaki Y, Marco V, Boi A, Fineschi M, Fabbiocchi F, Taglieri N, Niccoli G, Trani C, Versaci F, Calligaris G, Ruscica G, Di Giorgio A, Vergallo R, Albertucci M, Biondi-Zoccai G, Tamburino C, Crea F, Alfonso F, Arbustini E. Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study. Eur Heart J. 2020;41:383–91. https://doi.org/10.1093/eurheartj/ehz520.CrossRefPubMed

129.

Madder RD, Goldstein JA, Madden SP, Puri R, Wolski K, Hendricks M, Sum ST, Kini A, Sharma S, Rizik D, Brilakis ES, Shunk KA, Petersen J, Weisz G, Virmani R, Nicholls SJ, Maehara A, Mintz GS, Stone GW, Muller JE. Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2013;6:838–46. https://doi.org/10.1016/j.jcin.2013.04.012.CrossRefPubMed

130.

Madder RD, Puri R, Muller JE, Harnek J, Gotberg M, Vanoosterhout S, Chi M, Wohns D, Mcnamara R, Wolski K, Madden S, Sidharta S, Andrews J, Nicholls SJ, Erlinge D. Confirmation of the Intracoronary Near-Infrared Spectroscopy Threshold of Lipid-Rich Plaques That Underlie ST-Segment-Elevation Myocardial Infarction. Arterioscler Thromb Vasc Biol. 2016;36:1010–5. https://doi.org/10.1161/ATVBAHA.115.306849.CrossRefPubMed

131.

Madder RD, Husaini M, Davis AT, Van Oosterhout S, Harnek J, Gotberg M, Erlinge D. Detection by near-infrared spectroscopy of large lipid cores at culprit sites in patients with non-st-segment elevation myocardial infarction and unstable angina. Catheter Cardiovasc Interv. 2014. https://doi.org/10.1002/ccd.25754.CrossRefPubMed

132.

Kini AS, Motoyama S, Vengrenyuk Y, Feig JE, Pena J, Baber U, Bhat AM, Moreno P, Kovacic JC, Narula J, Sharma SK. Multimodality intravascular imaging to predict periprocedural myocardial infarction during percutaneous coronary intervention. JACC Cardiovasc Interv. 2015;8:937–45. https://doi.org/10.1016/j.jcin.2015.03.016.CrossRefPubMed

133.

Ozaki Y, Ohota M, Ismail TF, Okumura M, Ishikawa M, Muramatsu T. Thin cap fibroatheroma defined as lipid core abutting lumen (LCAL) on integrated backscatter intravascular ultrasound - comparison with optical coherence tomography and correlation with peri-procedural myocardial infarction. Circ J. 2015;79:808–17. https://doi.org/10.1253/circj.CJ-14-0758.CrossRefPubMed

134.

Prati F, Romagnoli E, Burzotta F, Limbruno U, Gatto L, La Manna A, Versaci F, Marco V, Di Vito L, Imola F, Paoletti G, Trani C, Tamburino C, Tavazzi L, Mintz GS. Clinical Impact of OCT Findings During PCI: The CLI-OPCI II Study. JACC Cardiovasc Imaging. 2015;8:1297–305. https://doi.org/10.1016/j.jcmg.2015.08.013.CrossRefPubMed

135.

Prati F, Romagnoli E, Gatto L, La Manna A, Burzotta F, Limbruno U, Versaci F, Fabbiocchi F, Di Giorgio A, Marco V, Ramazzotti V, Di Vito L, Trani C, Porto I, Boi A, Tavazzi L, Mintz GS. Clinical impact of suboptimal stenting and residual intrastent plaque/thrombus protrusion in patients with acute coronary syndrome: the CLI-OPCI ACS substudy (centro per la lotta contro l’infarto-optimization of percutaneous coronary intervention in acute coronary syndrome). Circ Cardiovasc Interv. 2016. https://doi.org/10.1161/circinterventions.115.003726.CrossRefPubMed

136.

Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabate M, Valgimigli M, Frati G, Kedhi E, Smits PC, Kaiser C, Genereux P, Galatius S, Kirtane AJ, Stone GW. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol. 2013;62:496–504. https://doi.org/10.1016/j.jacc.2013.05.022.CrossRefPubMed

137.

Philip F, Stewart S, Southard JA. Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials. Catheter Cardiovasc Interv. 2016;88:38–48. https://doi.org/10.1002/ccd.26458.CrossRefPubMed

138.

Chichareon P, Modolo R, Collet C, Tenekecioglu E, Vink MA, Oh PC, Ahn JM, Musto C, Díaz De La Llera LS, Cho YS, Violini R, Park SJ, Suryapranata H, Piek JJ, De Winter RJ, Wykrzykowska JJ, Spaulding C, Kang WC, Slagboom T, Hofma SH, Wijnbergen IF, Di Lorenzo E, Pijls NH, Räber L, Brugaletta S, Sabaté M, Stoll HP, Stone GW, Windecker S, Onuma Y, Serruys PW. Efficacy and safety of stents in st-segment elevation myocardial infarction. J Am Coll Cardiol. 2019;74:2572–84. https://doi.org/10.1016/j.jacc.2019.09.038.CrossRefPubMed

139.

Brugaletta S, Gomez-Lara J, Ortega-Paz L, Jimenez-Diaz V, Jimenez M, Jiménez-Quevedo P, Diletti R, Mainar V, Campo G, Silvestro A, Maristany J, Flores X, Oyarzabal L, De Miguel-Castro A, Iñiguez A, Serra A, Nombela-Franco L, Ielasi A, Tespili M, Lenzen M, Gonzalo N, Bordes P, Tebaldi M, Biscaglia S, Rodriguez-Arias JJ, Al-Shaibani S, Arevalos V, Romaguera R, Gomez-Hospital JA, Serruys PW, Sabaté M. 10-year follow-up of patients with everolimus-eluting versus bare-metal stents after st-segment elevation myocardial infarction. J Am Coll Cardiol. 2021;77:1165–78. https://doi.org/10.1016/j.jacc.2020.12.059.CrossRefPubMed

140.

Iglesias JF, Muller O, Heg D, Roffi M, Kurz DJ, Moarof I, Weilenmann D, Kaiser C, Tapponnier M, Stortecky S, Losdat S, Eeckhout E, Valgimigli M, Odutayo A, Zwahlen M, Jüni P, Windecker S, Pilgrim T. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial. Lancet. 2019;394:1243–53. https://doi.org/10.1016/s0140-6736(19)31877-x.CrossRefPubMed

141.

Naber CK, Urban P, Ong PJ, Valdes-Chavarri M, Abizaid AA, Pocock SJ, Fabbiocchi F, Dubois C, Copt S, Greene S, Morice MC. Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study. Eur Heart J. 2017;38:961–9. https://doi.org/10.1093/eurheartj/ehw203.CrossRefPubMed

142.

Sawada T, Shinke T, Otake H, Mizoguchi T, Iwasaki M, Emoto T, Terashita D, Mizuguchi T, Okamoto H, Matsuo Y, Kim SK, Takarada A, Yokoyama M. Comparisons of detailed arterial healing response at seven months following implantation of an everolimus- or sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction. Int J Cardiol. 2013;168:960–6. https://doi.org/10.1016/j.ijcard.2012.10.043.CrossRefPubMed

143.

Raber L, Mintz GS, Koskinas KC, Johnson TW, Holm NR, Onuma Y, Radu MD, Joner M, Yu B, Jia H, Meneveau N, De La Torre Hernandez JM, Escaned J, Hill J, Prati F, Colombo A, Di Mario C, Regar E, Capodanno D, Wijns W, Byrne RA, Guagliumi G, Group ESCSD. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2018;39:3281–300. https://doi.org/10.1093/eurheartj/ehy285.CrossRefPubMed

144.

Zhang J, Gao X, Kan J, Ge Z, Han L, Lu S, Tian N, Lin S, Lu Q, Wu X, Li Q, Liu Z, Chen Y, Qian X, Wang J, Chai D, Chen C, Li X, Gogas BD, Pan T, Shan S, Ye F, Chen SL. Intravascular ultrasound versus angiography-guided drug-eluting stent implantation: the ULTIMATE trial. J Am Coll Cardiol. 2018;72:3126–37. https://doi.org/10.1016/j.jacc.2018.09.013.CrossRefPubMed

145.

Hong SJ, Kim BK, Shin DH, Nam CM, Kim JS, Ko YG, Choi D, Kang TS, Kang WC, Her AY, Kim YH, Hur SH, Hong BK, Kwon H, Jang Y, Hong MK. Effect of intravascular ultrasound-guided vs angiography-guided everolimus-eluting stent implantation: the IVUS-XPL randomized clinical trial. JAMA. 2015;314:2155–63. https://doi.org/10.1001/jama.2015.15454.CrossRefPubMed

146.

Hong SJ, Mintz GS, Ahn CM, Kim JS, Kim BK, Ko YG, Kang TS, Kang WC, Kim YH, Hur SH, Hong BK, Choi D, Kwon H, Jang Y, Hong MK. Effect of intravascular ultrasound-guided drug-eluting stent implantation: 5-year follow-up of the IVUS-XPL randomized trial. JACC Cardiovasc Interv. 2020;13:62–71. https://doi.org/10.1016/j.jcin.2019.09.033.CrossRefPubMed

147.

Zhang Y, Farooq V, Garcia-Garcia HM, Bourantas CV, Tian N, Dong S, Li M, Yang S, Serruys PW, Chen SL. Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients. EuroIntervention. 2012;8:855–65. https://doi.org/10.4244/eijv8i7a129.CrossRefPubMed

148.

Ali ZA, Maehara A, Genereux P, Shlofmitz RA, Fabbiocchi F, Nazif TM, Guagliumi G, Meraj PM, Alfonso F, Samady H, Akasaka T, Carlson EB, Leesar MA, Matsumura M, Ozan MO, Mintz GS, Ben-Yehuda O, Stone GW. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial. Lancet (Lond, Engl). 2016;388:2618–28. https://doi.org/10.1016/s0140-6736(16)31922-5.CrossRef

149.

Kubo T, Shinke T, Okamura T, Hibi K, Nakazawa G, Morino Y, Shite J, Fusazaki T, Otake H, Kozuma K, Ioji T, Kaneda H, Serikawa T, Kataoka T, Okada H, Akasaka T. Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results. Eur Heart J. 2017;38:3139–47. https://doi.org/10.1093/eurheartj/ehx351.CrossRefPubMedPubMedCentral

150.

Radu MD, Raber L, Heo J, Gogas BD, Jorgensen E, Kelbaek H, Muramatsu T, Farooq V, Helqvist S, Garcia-Garcia HM, Windecker S, Saunamaki K, Serruys PW. Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation. EuroIntervention. 2014;9:1085–94. https://doi.org/10.4244/eijv9i9a183.CrossRefPubMed

151.

De Cock D, Bennett J, Ughi GJ, Dubois C, Sinnaeve P, Dhooge J, Desmet W, Belmans A, Adriaenssens T. Healing course of acute vessel wall injury after drug-eluting stent implantation assessed by optical coherence tomography. Eur Heart J Cardiovasc Imaging. 2014;15:800–9. https://doi.org/10.1093/ehjci/jeu003.CrossRefPubMed

152.

Bouki KP, Sakkali E, Toutouzas K, Vlad D, Barmperis D, Phychari S, Riga M, Apostolou T, Stefanadis C. Impact of coronary artery stent edge dissections on long-term clinical outcome in patients with acute coronary syndrome: an optical coherence tomography study. Catheter Cardiovasc Interv. 2015;86:237–46. https://doi.org/10.1002/ccd.25855.CrossRefPubMed

153.

Chamie D, Bezerra HG, Attizzani GF, Yamamoto H, Kanaya T, Stefano GT, Fujino Y, Mehanna E, Wang W, Abdul-Aziz A, Dias M, Simon DI, Costa MA. Incidence, predictors, morphological characteristics, and clinical outcomes of stent edge dissections detected by optical coherence tomography. JACC Cardiovasc Interv. 2013;6:800–13. https://doi.org/10.1016/j.jcin.2013.03.019.CrossRefPubMed

154.

Kawamori H, Shite J, Shinke T, Otake H, Matsumoto D, Nakagawa M, Nagoshi R, Kozuki A, Hariki H, Inoue T, Osue T, Taniguchi Y, Nishio R, Hiranuma N, Hirata K. Natural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-up. Eur Heart J Cardiovasc Imaging. 2013;14:865–75. https://doi.org/10.1093/ehjci/jes299.CrossRefPubMedPubMedCentral

155.

Taniwaki M, Radu MD, Zaugg S, Amabile N, Garcia-Garcia HM, Yamaji K, Jorgensen E, Kelbaek H, Pilgrim T, Caussin C, Zanchin T, Veugeois A, Abildgaard U, Juni P, Cook S, Koskinas KC, Windecker S, Raber L. Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography. Circulation. 2016;133:650–60. https://doi.org/10.1161/circulationaha.115.019071.CrossRefPubMed

156.

Steinberg DH, Mintz GS, Mandinov L, Yu A, Ellis SG, Grube E, Dawkins KD, Ormiston J, Turco MA, Stone GW, Weissman NJ. Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. JACC Cardiovasc Interv. 2010;3:486–94. https://doi.org/10.1016/j.jcin.2010.03.007.CrossRefPubMed

157.

Guo N, Maehara A, Mintz GS, He Y, Xu K, Wu X, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA Jr, Dressler O, Parise H, Mehran R, Stone GW. Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. Circulation. 2010;122:1077–84. https://doi.org/10.1161/circulationaha.109.906040.CrossRefPubMed

158.

Romagnoli E, Gatto L, La Manna A, Burzotta F, Taglieri N, Saia F, Amico F, Marco V, Ramazzotti V, Di Giorgio A, Di Vito L, Boi A, Contarini M, Castriota F, Mintz GS, Prati F. Role of residual acute stent malapposition in percutaneous coronary interventions. Catheter Cardiovasc Interv. 2017. https://doi.org/10.1002/ccd.26974.CrossRefPubMed

159.

Ozaki Y, Okumura M, Ismail TF, Naruse H, Hattori K, Kan S, Ishikawa M, Kawai T, Takagi Y, Ishii J, Prati F, Serruys PW. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study. Eur Heart J. 2010;31:1470–6. https://doi.org/10.1093/eurheartj/ehq066.CrossRefPubMed

160.

Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Bohm M, Ebelt H, Schneider S, Schuler G, Werdan K. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287–96. https://doi.org/10.1056/NEJMoa1208410.CrossRefPubMed

161.

Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, De Waha A, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Lauer B, Bohm M, Ebelt H, Schneider S, Werdan K, Schuler G. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet (Lond, Engl). 2013;382:1638–45. https://doi.org/10.1016/s0140-6736(13)61783-3.CrossRef

162.

Patel MR, Smalling RW, Thiele H, Barnhart HX, Zhou Y, Chandra P, Chew D, Cohen M, French J, Perera D, Ohman EM. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA. 2011;306:1329–37. https://doi.org/10.1001/jama.2011.1280.CrossRefPubMed

163.

Cheng JM, Den Uil CA, Hoeks SE, Van Der Ent M, Jewbali LS, Van Domburg RT, Serruys PW. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009;30:2102–8. https://doi.org/10.1093/eurheartj/ehp292.CrossRefPubMed

164.

Ouweneel DM, Eriksen E, Sjauw KD, Van Dongen IM, Hirsch A, Packer EJ, Vis MM, Wykrzykowska JJ, Koch KT, Baan J, De Winter RJ, Piek JJ, Lagrand WK, De Mol BA, Tijssen JG, Henriques JP. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017;69:278–87. https://doi.org/10.1016/j.jacc.2016.10.022.CrossRefPubMed

165.

Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, Russell SD, Conte JV, Aaronson KD, Mcgee EC Jr, Cotts WG, Denofrio D, Pham DT, Farrar DJ, Pagani FD. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol. 2011;57:1890–8. https://doi.org/10.1016/j.jacc.2010.10.062.CrossRefPubMed

166.

Sheu JJ, Tsai TH, Lee FY, Fang HY, Sun CK, Leu S, Yang CH, Chen SM, Hang CL, Hsieh YK, Chen CJ, Wu CJ, Yip HK. Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med. 2010;38:1810–7. https://doi.org/10.1097/CCM.0b013e3181e8acf7.CrossRefPubMed

167.

Atkinson TM, Ohman EM, Oneill WW, Rab T, Cigarroa JE. A practical approach to mechanical circulatory support in patients undergoing percutaneous coronary intervention: an interventional perspective. JACC Cardiovasc Interv. 2016;9:871–83. https://doi.org/10.1016/j.jcin.2016.02.046.CrossRefPubMed

168.

Aso S, Matsui H, Fushimi K, Yasunaga H. The effect of intraaortic balloon pumping under venoarterial extracorporeal membrane oxygenation on mortality of cardiogenic patients: an analysis using a nationwide inpatient database. Crit Care Med. 2016;44:1974–9. https://doi.org/10.1097/ccm.0000000000001828.CrossRefPubMed

169.

Cubeddu RJ, Lago R, Horvath SA, Vignola PA, Oneill W, Palacios IF. Use of the Impella 2.5 system alone, after and in combination with an intra-aortic balloon pump in patients with cardiogenic shock: case description and review of the literature. EuroIntervention. 2012;7:1453–60. https://doi.org/10.4244/eijv7i12a226.CrossRefPubMed

170.

Wiktor DM, Sawlani N, Kanthi Y, Sipahi I, Fang JC, Blitz A. Successful combined use of Impella Recover 2.5 device and intra-aortic balloon pump support in cardiogenic shock from acute myocardial infarction. ASAIO J. 2010;56:519–21. https://doi.org/10.1097/MAT.0b013e3181f7478e.CrossRefPubMed

171.

Burzotta F, Trani C, Doshi SN, Townend J, Van Geuns RJ, Hunziker P, Schieffer B, Karatolios K, Moller JE, Ribichini FL, Schafer A, Henriques JP. Impella ventricular support in clinical practice: collaborative viewpoint from a European expert user group. Int J Cardiol. 2015;201:684–91. https://doi.org/10.1016/j.ijcard.2015.07.065.CrossRefPubMed

172.

Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, Sakamoto T, Tsujita K, Hagiwara N, Miyazaki S, Ako J, Arai H, Ishii H, Origuchi H, Shimizu W, Takemura H, Tahara Y, Morino Y, Iino K, Itoh T, Iwanaga Y, Uchida K, Endo H, Kongoji K, Sakamoto K, Shiomi H, Shimohama T, Suzuki A, Takahashi J, Takeuchi I, Tanaka A, Tamura T, Nakashima T, Noguchi T, Fukamachi D, Mizuno T, Yamaguchi J, Yodogawa K, Kosuge M, Kohsaka S, Yoshino H, Yasuda S, Shimokawa H, Hirayama A, Akasaka T, Haze K, Ogawa H, Tsutsui H, Yamazaki T. JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome. Circ J. 2019;83:1085–196. https://doi.org/10.1253/circj.CJ-19-0133.CrossRefPubMed

173.

Costa F, Van Klaveren D, James S, Heg D, Raber L, Feres F, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Zanchin T, Palmerini T, Wallentin L, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet (Lond, Engl). 2017;389:1025–34. https://doi.org/10.1016/s0140-6736(17)30397-5.CrossRef

174.

Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Juni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN. ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2017. https://doi.org/10.1093/eurheartj/ehx419.CrossRefPubMedPubMedCentral

175.

Yoshikawa Y, Shiomi H, Watanabe H, Natsuaki M, Kondo H, Tamura T, Nakagawa Y, Morimoto T, Kimura T. Validating utility of dual antiplatelet therapy score in a large pooled cohort from 3 japanese percutaneous coronary intervention studies. Circulation. 2018;137:551–62. https://doi.org/10.1161/circulationaha.117.028924.CrossRefPubMed

176.

Vranckx P, Valgimigli M, Juni P, Hamm C, Steg PG, Heg D, Van Es GA, Mcfadden EP, Onuma Y, Van Meijeren C, Chichareon P, Benit E, Mollmann H, Janssens L, Ferrario M, Moschovitis A, Zurakowski A, Dominici M, Van Geuns RJ, Huber K, Slagboom T, Serruys PW, Windecker S, Investigators GL. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet. 2018;392:940–9. https://doi.org/10.1016/S0140-6736(18)31858-0.CrossRefPubMed

177.

Tomaniak M, Chichareon P, Onuma Y, Deliargyris EN, Takahashi K, Kogame N, Modolo R, Chang CC, Rademaker-Havinga T, Storey RF, Dangas GD, Bhatt DL, Angiolillo DJ, Hamm C, Valgimigli M, Windecker S, Steg PG, Vranckx P, Serruys PW. Benefit and risks of aspirin in addition to ticagrelor in acute coronary syndromes: a Post Hoc analysis of the randomized GLOBAL LEADERS trial. JAMA Cardiol. 2019. https://doi.org/10.1001/jamacardio.2019.3355.CrossRefPubMedPubMedCentral

178.

Hahn JY, Song YB, Oh JH, Chun WJ, Park YH, Jang WJ, Im ES, Jeong JO, Cho BR, Oh SK, Yun KH, Cho DK, Lee JY, Koh YY, Bae JW, Choi JW, Lee WS, Yoon HJ, Lee SU, Cho JH, Choi WG, Rha SW, Lee JM, Park TK, Yang JH, Choi JH, Choi SH, Lee SH, Gwon HC, Investigators S-C. Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE randomized clinical trial. JAMA. 2019;321:2428–37. https://doi.org/10.1001/jama.2019.8146.CrossRefPubMedPubMedCentral

179.

Mehran R, Baber U, Sharma SK, Cohen DJ, Angiolillo DJ, Briguori C, Cha JY, Collier T, Dangas G, Dudek D, Dzavik V, Escaned J, Gil R, Gurbel P, Hamm CW, Henry T, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff M, Kunadian V, Marx SO, Mehta SR, Moliterno D, Ohman EM, Oldroyd K, Sardella G, Sartori S, Shlofmitz R, Steg PG, Weisz G, Witzenbichler B, Han YL, Pocock S, Gibson CM. Ticagrelor with or without aspirin in high-risk patients after PCI. N Engl J Med. 2019;381:2032–42. https://doi.org/10.1056/NEJMoa1908419.CrossRefPubMed

180.

Baber U, Dangas G, Angiolillo DJ, Cohen DJ, Sharma SK, Nicolas J, Briguori C, Cha JY, Collier T, Dudek D, Džavik V, Escaned J, Gil R, Gurbel P, Hamm CW, Henry T, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff M, Kunadian V, Marx SO, Mehta S, Moliterno D, Ohman EM, Oldroyd K, Sardella G, Sartori S, Shlofmitz R, Steg PG, Weisz G, Witzenbichler B, Han YL, Pocock S, Gibson CM, Mehran R. Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS. Eur Heart J. 2020;41:3533–45. https://doi.org/10.1093/eurheartj/ehaa670.CrossRefPubMed

181.

Kim BK, Hong SJ, Cho YH, Yun KH, Kim YH, Suh Y, Cho JY, Her AY, Cho S, Jeon DW, Yoo SY, Cho DK, Hong BK, Kwon H, Ahn CM, Shin DH, Nam CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y. Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial. JAMA. 2020;323:2407–16. https://doi.org/10.1001/jama.2020.7580.CrossRefPubMedPubMedCentral

182.

Lee SJ, Cho JY, Kim BK, Yun KH, Suh Y, Cho YH, Kim YH, Her AY, Cho S, Jeon DW, Yoo SY, Cho DK, Hong BK, Kwon HM, Hong SJ, Ahn CM, Shin DH, Nam CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y. Ticagrelor monotherapy versus ticagrelor with aspirin in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2021;14:431–40. https://doi.org/10.1016/j.jcin.2020.11.036.CrossRefPubMed

183.

Valgimigli M, Frigoli E, Heg D, Tijssen J, Juni P, Vranckx P, Ozaki Y, Morice MC, Chevalier B, Onuma Y, Windecker S, Pal T, Roffi M, Lesiak M, Mahfoud F, Bartunek J, Hildick-Smith D, Colombo A, Stankovic G, Iniguez A, Schultz C, Kornowski R, Ong PJL, Alasnag M, Rodriguez AE, Moschovitis A, Laanmets P, Donahue M, Leonardi S, Smits PC, Investigators MD. Dual antiplatelet therapy after PCI in patients at high bleeding risk. N Engl J Med. 2021. https://doi.org/10.1056/NEJMoa2108749.CrossRefPubMed

184.

Smits PC, Frigoli E, Tijssen J, Jüni P, Vranckx P, Ozaki Y, Morice MC, Chevalier B, Onuma Y, Windecker S, PaL T, Roffi M, Lesiak M, Mahfoud F, Bartunek J, Hildick-Smith D, Colombo A, Stankovic G, Iñiguez A, Schultz C, Kornowski R, Ong PJL, Alasnag M, Rodriguez AE, Moschovitis A, Laanmets P, Heg D, Valgimigli M. Abbreviated antiplatelet therapy in patients at high bleeding risk with or without oral anticoagulant therapy after coronary stenting: an open-label, randomized, controlled trial. Circulation. 2021. https://doi.org/10.1161/circulationaha.121.056680.CrossRefPubMedPubMedCentral

185.

Cryer B, Bhatt DL, Lanza FL, Dong JF, Lichtenberger LM, Marathi UK. Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial. Am J Gastroenterol. 2011;106:272–7. https://doi.org/10.1038/ajg.2010.436.CrossRefPubMed

186.

Uchiyama S, Goto S, Origasa H, Uemura N, Sugano K, Hiraishi H, Shimada K, Okada Y, Ikeda Y. Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of Aspirin-induced Gastrointestinal Complications (MAGIC) study. Heart Vessels. 2020;35:170–6. https://doi.org/10.1007/s00380-019-01484-0.CrossRefPubMed

187.

Uemura N, Sugano K, Hiraishi H, Shimada K, Goto S, Uchiyama S, Okada Y, Origasa H, Ikeda Y. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study. J Gastroenterol. 2014;49:814–24. https://doi.org/10.1007/s00535-013-0839-5.CrossRefPubMed

188.

Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T, Investigators S-C. Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving pci: the stopdapt-2 randomized clinical trial. JAMA. 2019;321:2414–27. https://doi.org/10.1001/jama.2019.8145.CrossRefPubMedPubMedCentral

189.

Kogame N, Guimaraes PO, Modolo R, De Martino F, Tinoco J, Ribeiro EE, Kawashima H, Ono M, Hara H, Wang R, Cavalcante R, Moulin B, BaA F, Leite RS, De Almeida Sampaio FB, Morais GR, Meireles GC, Campos CM, Onuma Y, Serruys PW, Lemos PA. Aspirin-free prasugrel monotherapy following coronary artery stenting in patients with stable CAD: the ASET Pilot Study. JACC Cardiovasc Interv. 2020;13:2251–62. https://doi.org/10.1016/j.jcin.2020.06.023.CrossRefPubMed

190.

Rubboli A, Valgimigli M, Capodanno D, Lip GYH. Choices in antithrombotic management for patients with atrial fibrillation undergoing percutaneous coronary intervention: questions (and answers) in chronological sequence. Eur Heart J Cardiovasc Pharmacother. 2021;7:68–73. https://doi.org/10.1093/ehjcvp/pvaa047.CrossRefPubMed

191.

Dewilde WJ, Oirbans T, Verheugt FW, Kelder JC, De Smet BJ, Herrman JP, Adriaenssens T, Vrolix M, Heestermans AA, Vis MM, Tijsen JG, Vant Hof AW, Ten Berg JM. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013;381:1107–15. https://doi.org/10.1016/s0140-6736(12)62177-1.CrossRefPubMed

192.

Gibson CM, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Birmingham M, Ianus J, Burton P, Van Eickels M, Korjian S, Daaboul Y, Lip GY, Cohen M, Husted S, Peterson ED, Fox KA. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. N Engl J Med. 2016;375:2423–34. https://doi.org/10.1056/NEJMoa1611594.CrossRefPubMed

193.

Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, Ten Berg JM, Steg PG, Hohnloser SH, Committee R-DPS, Investigators. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med. 2017;377:1513–24. https://doi.org/10.1056/NEJMoa1708454.CrossRefPubMed

194.

Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, Goodman SG, Windecker S, Darius H, Li J, Averkov O, Bahit MC, Berwanger O, Budaj A, Hijazi Z, Parkhomenko A, Sinnaeve P, Storey RF, Thiele H, Vinereanu D, Granger CB, Alexander JH, Investigators A. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med. 2019;380:1509–24. https://doi.org/10.1056/NEJMoa1817083.CrossRefPubMed

195.

Lopes RD, Hong H, Harskamp RE, Bhatt DL, Mehran R, Cannon CP, Granger CB, Verheugt FWA, Li J, Ten Berg JM, Sarafoff N, Gibson CM, Alexander JH. Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis of randomized controlled trials. JAMA Cardiol. 2019;4:747–55. https://doi.org/10.1001/jamacardio.2019.1880.CrossRefPubMedPubMedCentral

196.

Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H, Investigators A. Antithrombotic therapy for atrial fibrillation with stable coronary disease. N Engl J Med. 2019;381:1103–13. https://doi.org/10.1056/NEJMoa1904143.CrossRefPubMed

197.

Hashimoto Y, Ozaki Y, Kan S, Nakao K, Kimura K, Ako J, Noguchi T, Suwa S, Fujimoto K, Dai K, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Wake M, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Oshima S, Yasuda S, Ismail TF, Muramatsu T, Izawa H, Takahashi H, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M. Impact of chronic kidney disease on in-hospital and 3-year clinical outcomes in patients with acute myocardial infarction treated by contemporary percutaneous coronary intervention and optimal medical therapy insights from the J-MINUET study. Circ J. 2021. https://doi.org/10.1253/circj.CJ-20-1115.CrossRefPubMed

198.

Smits PC, Abdel-Wahab M, Neumann FJ, Boxma-De Klerk BM, Lunde K, Schotborgh CE, Piroth Z, Horak D, Wlodarczak A, Ong PJ, Hambrecht R, Angeras O, Richardt G, Omerovic E. Fractional Flow Reserve-guided multivessel angioplasty in myocardial infarction. N Engl J Med. 2017;376:1234–44. https://doi.org/10.1056/NEJMoa1701067.CrossRefPubMed

199.

Smits PC, Laforgia PL, Abdel-Wahab M, Neumann FJ, Richardt G, Boxma-De Klerk B, Lunde K, Schotborgh CE, Piroth Z, Horak D, Wlodarczak A, Frederix GW, Omerovic E. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction: three-year follow-up with cost benefit analysis of the Compare-Acute trial. EuroIntervention. 2020;16:225–32. https://doi.org/10.4244/eij-d-20-00012.CrossRefPubMed

200.

Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, Meeks B, Di Pasquale G, López-Sendón J, Faxon DP, Mauri L, Rao SV, Feldman L, Steg PG, Avezum Á, Sheth T, Pinilla-Echeverri N, Moreno R, Campo G, Wrigley B, Kedev S, Sutton A, Oliver R, Rodés-Cabau J, Stanković G, Welsh R, Lavi S, Cantor WJ, Wang J, Nakamya J, Bangdiwala SI, Cairns JA. Complete revascularization with multivessel pci for myocardial infarction. N Engl J Med. 2019;381:1411–21. https://doi.org/10.1056/NEJMoa1907775.CrossRefPubMed

201.

Bainey KR, Engstrøm T, Smits PC, Gershlick AH, James SK, Storey RF, Wood DA, Mehran R, Cairns JA, Mehta SR. Complete vs culprit-lesion-only revascularization for st-segment elevation myocardial infarction: a systematic review and meta-analysis. JAMA Cardiol. 2020;5:1–9. https://doi.org/10.1001/jamacardio.2020.1251.CrossRefPubMedCentral

202.

Thiele H, Akin I, Sandri M, Fuernau G, De Waha S, Meyer-Saraei R, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Savonitto S, Torremante P, Vrints C, Schneider S, Desch S, Zeymer U. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. N Engl J Med. 2017;5:5. https://doi.org/10.1056/NEJMoa171026.CrossRef

203.

Thiele H, Akin I, Sandri M, De Waha-Thiele S, Meyer-Saraei R, Fuernau G, Eitel I, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Jobs A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Hunziker L, Savonitto S, Torremante P, Vrints C, Schneider S, Zeymer U, Desch S. One-year outcomes after PCI Strategies In Cardiogenic Shock. N Engl J Med. 2018;379:1699–710. https://doi.org/10.1056/NEJMoa1808788.CrossRefPubMed

204.

Rathod KS, Koganti S, Jain AK, Astroulakis Z, Lim P, Rakhit R, Kalra SS, Dalby MC, Omahony C, Malik IS, Knight CJ, Mathur A, Redwood S, Sirker A, Maccarthy PA, Smith EJ, Wragg A, Jones DA. Complete versus culprit-only lesion intervention in patients with acute coronary syndromes. J Am Coll Cardiol. 2018;72:1989–99. https://doi.org/10.1016/j.jacc.2018.07.089.CrossRefPubMed

205.

Bainey KR, Alemayehu W, Armstrong PW, Westerhout CM, Kaul P, Welsh RC. Long-term outcomes of complete revascularization with percutaneous coronary intervention in acute coronary syndromes. JACC Cardiovasc Interv. 2020;13:1557–67. https://doi.org/10.1016/j.jcin.2020.04.034.CrossRefPubMed

206.

Wood DA, Cairns JA, Wang J, Mehran R, Storey RF, Nguyen H, Meeks B, Kunadian V, Tanguay JF, Kim HH, Cheema A, Dehghani P, Natarajan MK, Jolly SS, Amerena J, Keltai M, James S, Hlinomaz O, Niemela K, Alhabib K, Lewis BS, Nguyen M, Sarma J, Dzavik V, Della Siega A, Mehta SR. Timing of Staged Nonculprit Artery Revascularization In Patients With St-Segment Elevation Myocardial Infarction: COMPLETE trial. J Am Coll Cardiol. 2019;74:2713–23. https://doi.org/10.1016/j.jacc.2019.09.051.CrossRefPubMed

207.

Sardella G, Lucisano L, Garbo R, Pennacchi M, Cavallo E, Stio RE, Calcagno S, Ugo F, Boccuzzi G, Fedele F, Mancone M. Single-staged compared with multi-staged pci in multivessel nstemi patients: the SMILE trial. J Am Coll Cardiol. 2016;67:264–72. https://doi.org/10.1016/j.jacc.2015.10.082.CrossRefPubMed

208.

Calviño-Santos R, Estévez-Loureiro R, Peteiro-Vázquez J, Salgado-Fernández J, Rodríguez-Vilela A, Franco-Gutiérrez R, Bouzas-Mosquera A, Rodríguez-Fernández J, Mesías-Prego A, González-Juanatey C, Aldama-López G, Piñón-Esteban P, Flores-Ríos X, Soler-Martín R, Seoane-Pillado T, Vázquez-González N, Muñiz J, Vázquez-Rodríguez JM. Angiographically guided complete revascularization versus selective stress echocardiography-guided revascularization in patients with st-segment-elevation myocardial infarction and multivessel disease: the CROSS-AMI randomized clinical trial. Circ Cardiovasc Interv. 2019;12: e007924. https://doi.org/10.1161/circinterventions.119.007924.CrossRefPubMed

209.

Puymirat E, Cayla G, Simon T, Steg PG, Montalescot G, Durand-Zaleski I, Le Bras A, Gallet R, Khalife K, Morelle JF, Motreff P, Lemesle G, Dillinger JG, Lhermusier T, Silvain J, Roule V, Labèque JN, Rangé G, Ducrocq G, Cottin Y, Blanchard D, Charles Nelson A, De Bruyne B, Chatellier G, Danchin N. Multivessel PCI guided by FFR or angiography for myocardial infarction. N Engl J Med. 2021. https://doi.org/10.1056/NEJMoa2104650.CrossRefPubMed

Title: CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022
Authors: Yukio Ozaki
Hironori Hara
Yoshinobu Onuma
Yuki Katagiri
Tetsuya Amano
Yoshio Kobayashi
Takashi Muramatsu
Hideki Ishii
Ken Kozuma
Nobuhiro Tanaka
Hitoshi Matsuo
Shiro Uemura
Kazushige Kadota
Yutaka Hikichi
Kenichi Tsujita
Junya Ako
Yoshihisa Nakagawa
Yoshihiro Morino
Ichiro Hamanaka
Nobuo Shiode
Junya Shite
Junko Honye
Tetsuo Matsubara
Kazuya Kawai
Yasumi Igarashi
Atsunori Okamura
Takayuki Ogawa
Yoshisato Shibata
Takafumi Tsuji
Junji Yajima
Kaoru Iwabuchi
Nobuo Komatsu
Teruyasu Sugano
Masaru Yamaki
Shinichiro Yamada
Hiroaki Hirase
Yuusuke Miyashita
Fuminobu Yoshimachi
Masakazu Kobayashi
Jiro Aoki
Hirotaka Oda
Yoshiaki Katahira
Kinzo Ueda
Masami Nishino
Koichi Nakao
Ichiro Michishita
Takafumi Ueno
Taku Inohara
Shun Kohsaka
Tevfik F. Ismail
Patrick W. Serruys
Masato Nakamura
Hiroyoshi Yokoi
Yuji Ikari
The Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Cardiovascular Interventional Therapeutics (CVIT)
Publication date: 01-01-2022
Publisher: Springer Singapore
Keywords: Ticagrelor
Foreign Body Aspiration
Direct Oral Anticoagulant
Clopidogrel
Foreign Body Aspiration
Intravascular Ultrasound
Aspiration
ST-Segment Elevation Myocardial Infarction
Myocardial Infarction
Acute Coronary Syndrome
Prasugrel
Direct Oral Anticoagulant
Published in: Cardiovascular Intervention and Therapeutics / Issue 1/2022
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI: https://doi.org/10.1007/s12928-021-00829-9

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2022

Displaced urinary bladder: a sign of iliac rupture

In-stent protruding bump with abnormal IVUS images causing acute coronary syndrome in a hemodialysis patient

Simultaneous procedure of MitraClip and WATCHMAN implantation in a patient with atrial fibrillation and severe mitral regurgitation: the first case in Japan

Peri-stent contrast staining after ultrathin, biodegradable polymer sirolimus-eluting stent implantation: findings from optical coherence tomography and coronary angioscopy

Clinical outcomes in nonagenarians undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis

Angiographic evaluation of radial artery injury after transradial approach for percutaneous coronary intervention

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page